Inventor · disambiguated record
Hui-Ling Wang
Also filed as: WANG HUI-LING
26 granted patents·13 pending applications·310 citations·filing 2003–2025
96Inventor score
Top patents by PatentIndex Score
39 records- 0198US11993597B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2022·Granted May 28, 2024·8 cites·50 claims
- 0298US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0398US11306087B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2020·Granted Apr 19, 2022·16 cites·55 claims
- 0498US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0598US10640504B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2018·Granted May 5, 2020·50 cites·71 claims
- 0698US10532042B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2017·Granted Jan 14, 2020·49 cites·13 claims
- 0797US11285135B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Mar 29, 2022·20 cites·16 claims
- 0896US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 0996US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 1093US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1190US9090593B2Bicyclic compounds as Pim inhibitorsWANG HUI-LING·Filed 2011·Granted Jul 28, 2015·26 cites·51 claims
- 1288US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1385US6822097B1Compounds and methods of usesAMGEN INC·Filed 2003·Granted Nov 23, 2004·23 cites·44 claims
- 1485US2025362134A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1584US7053088B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted May 30, 2006·19 cites·22 claims
- 1684US2024287068A1Inhibitors of kras g12c and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 1782US7396831B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 1882US2025057817A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 1979US7534798B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted May 19, 2009·4 cites·12 claims
- 2077US7144888B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Dec 5, 2006·9 cites·25 claims
- 2177US7119111B22-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of useAMGEN INC·Filed 2003·Granted Oct 10, 2006·11 cites·24 claims
- 2274US2022168280A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2022·Application pending·0 cites
- 2372US7148221B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Dec 12, 2006·1 cites·19 claims
- 2469US7511044B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Mar 31, 2009·1 cites·5 claims
- 2565US2024409557A15,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin dehydrogenase modulatorsAMGEN INC·Filed 2024·Application pending·0 cites
- 2663US2019375749A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2019·Application pending·0 cites
- 2756US2006241151A1Pyrid-2-one derivatives and methods of useAMGEN INC·Filed 2006·Application pending·0 cites
- 2854US7524874B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Apr 28, 2009·0 cites·19 claims
- 2954US7332511B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 19, 2008·0 cites·19 claims
- 3054US2024124442A1Tricyclic-amido-bicyclic prmt5 inhibitorsAMGEN INC·Filed 2022·Application pending·0 cites
- 3153US8227469B2Vanilloid receptor ligands and their use in treatmentsBALAN CHENERA·Filed 2009·Granted Jul 24, 2012·0 cites·9 claims
- 3253US2024190862A1Epoxyamides as kras g12c and kras g12d inhibitors and methods of using the sameAMGEN INC·Filed 2020·Application pending·0 cites
- 3352US8455495B2Pyridazino-pyridinone compounds and methods of usePETTUS LIPING H·Filed 2009·Granted Jun 4, 2013·0 cites·15 claims
- 3452US2007032518A1Compounds and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 3552US2024101570A1Tricyclic carboxamide derivatives as prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 3649US2004147561A1Pyrid-2-one derivatives and methods of useFiled 2003·Application pending·0 cites
- 3742US9394297B2Amides as pim inhibitorsAMGEN INC·Filed 2013·Granted Jul 19, 2016·0 cites·20 claims
- 3840US9321756B2Azole compounds as PIM inhibitorsWANG HUI-LING·Filed 2012·Granted Apr 26, 2016·0 cites·16 claims
- 3934US9187486B2Bicyclic pyridazine compounds as Pim inhibitorsD AMICO DERIN C·Filed 2012·Granted Nov 17, 2015·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Hui-Ling Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →